Two neonatal cholestasis patients with mutations in the <i>SRD5B1</i> (<i>AKR1D1</i>) gene: diagnosis and bile acid profiles during chenodeoxycholic acid treatment

Abstract

Primary bile acid treatment using chenodeoxycholic acid was effective for these patients treated in early infancy before the late stage of chronic cholestatic liver dysfunction.